Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Exploring the prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma

Ji Eun Han, Hyo Jung Cho

Clin Mol Hepatol. 2024;30(2):160-163. Published online February 28, 2024

DOI: https://doi.org/10.3350/cmh.2024.0141

View: 836 Download: 27

Original Article

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B

Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong

Clin Mol Hepatol. 2014;20(4):347-354. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.347

View: 8283 Download: 121 Web of Science: 16 Crossref: 15

Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus

Seun Joo Ahn, Dong Kyu Kim, Soon Sun Kim, Chang Bum Bae, Hyo Jung Cho, Han Gyeol Kim, Young Jip Kim, Joo Ho Lee, Hyo Jin Lee, Mi Yeon Lee, Kee Bum Kim, Jin Hee Cho, Sung Won Cho, Jae Youn Cheong

Clin Mol Hepatol. 2012;18(3):295-301. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.295

View: 8154 Download: 67 Crossref: 16

Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma

Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim

Received January 17, 2024 Accepted March 14, 2024

DOI: https://doi.org/10.3350/cmh.2024.0042 [Accepted]

View: 669 Download: 72

1 |

Viewed By 5080	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4905	MAFLD: How is it different from NAFLD?
Viewed By 4823	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3527	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3506	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 49	MAFLD enhances clinical practice for liver disease in the Asia-Pacific region

Search